Tasigna MDL Judge Denies Novartis’ ‘Mystery’ Motion To Remand Cases After 2 Years

Mealey's (March 29, 2023, 12:13 PM EDT) -- ORLANDO, Fla. — The Florida federal judge presiding over the Tasigna atherosclerosis multidistrict litigation has agreed with plaintiffs’ counsel that the timing of defendant Novartis Pharmaceuticals Corp.’s (NPC) motion to remand all cases to district courts or to grant the defendants summary judgment is a “‘mystery.’”...